[EXECUTION COPY SHARE PURCHASE AGREEMENT THIS SHARE PURCHASE AGREEMENT Agreement (1) WP X WPP X, Purchasers Purchaser (2) IDG Fund IDG Investors Sellers Seller Parties Party Sellers and Purchasers are collectively referred to herein as the WHEREAS: 1. Company China Biologic Products, Inc. (the 2. Shares The Company is listed on NASDAQ. As of April 23, 2012, a] []
[EXECUTION COPY SHARE PURCHASE AGREEMENT THIS SHARE PURCHASE AGREEMENT Agreement (1) WP X WPP X, Purchasers Purchaser (2) IDG Fund IDG Investors Sellers Seller Parties Party Sellers and Purchasers are collectively referred to herein as the WHEREAS: 1. Company China Biologic Products, Inc. (the 2. Shares The Company is listed on NASDAQ. As of April 23, 2012, a] []
[CUSIP No. 16938C106 SCHEDULE 13G Page 12 of 12 Pages Joint Filing Agreement IDG-ACCEL CHINA GROWTH FUND II L.P. its General Partner its General Partner IDG-ACCEL CHINA GROWTH FUND II ASSOCIATES L.P. its General Partner IDG-ACCEL CHINA GROWTH FUND GP II ASSOCIATES LTD. IDG-ACCEL CHINA INVESTORS II L.P. its General Partner] [16938C106 CUSIP No. 2 12 Page 1 NAMES OF REPORTING PERSONS IDG-Accel China Growth Fund II L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) ¨ ¨ (a) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION]
[CUSIP No. 16938C106 SCHEDULE 13G Page 12 of 12 Pages Joint Filing Agreement IDG-ACCEL CHINA GROWTH FUND II L.P. its General Partner its General Partner IDG-ACCEL CHINA GROWTH FUND II ASSOCIATES L.P. its General Partner IDG-ACCEL CHINA GROWTH FUND GP II ASSOCIATES LTD. IDG-ACCEL CHINA INVESTORS II L.P. its General Partner] [16938C106 CUSIP No. 2 12 Page 1 NAMES OF REPORTING PERSONS IDG-Accel China Growth Fund II L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) ¨ ¨ (a) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION]
[China Biologic to Attend Jefferies Healthcare Conference on June 7, 2012 in New York BEIJING, China, June 4, 2012 /PRNewswire/ China Biologic Products, Inc. (NASDAQ: CBPO, China Biologic or the Company), one of the leading plasma-based biopharmaceutical companies in the Peoples Republic of China, today announced that it will participate in the Jefferies 2012 Global Healthcare Conference on June 7,] [] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): June 4, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building Chaoyang District, Beijing 100125 86 10 6598 3111 ____________________________________________________________ (Former name or former address, if changed since last]
[China Biologic to Attend Jefferies Healthcare Conference on June 7, 2012 in New York BEIJING, China, June 4, 2012 /PRNewswire/ China Biologic Products, Inc. (NASDAQ: CBPO, China Biologic or the Company), one of the leading plasma-based biopharmaceutical companies in the Peoples Republic of China, today announced that it will participate in the Jefferies 2012 Global Healthcare Conference on June 7,] [] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): June 4, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building Chaoyang District, Beijing 100125 86 10 6598 3111 ____________________________________________________________ (Former name or former address, if changed since last]
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 Peoples Republic of China 86 10 6598 3111 ______________________________________________ (Former]
[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 20, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 Peoples Republic of China 86 10 6598 3111 ______________________________________________ (Former]
[Employment Agreement Agreement Company Executive This Employment Agreement ( WHEREAS, the Company desires to engage the Executive as, and the Executive agrees to serve as, Chief Executive Officer of the Company, upon the terms and conditions contained herein. NOW THEREFORE, for good and valuable consideration, the sufficiency of which is hereby acknowledged by the parties, the parties hereby agree as] [CHINA BIOLOGIC PRODUCTS, INC. 2008 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT Unless otherwise defined herein, the terms in the Stock Option Agreement (the Option Agreement) have the same meanings as defined in the China Biologic Products, Inc. 2008 Equity Incentive Plan (the Plan). I. NOTICE OF STOCK OPTION GRANT Optionee: Xiaoying (David) Gao Address: c/o China Biologic Products, Inc., 18th] [China Biologic Products Names Chairman David Gao to Additional Post of CEO BEIJING, China, May 11, 2012 /PRNewswire/ China Biologic Products, Inc. (NASDAQ: CBPO, China Biologic or the Company), one of the leading plasma-based biopharmaceutical companies in the Peoples Republic of China, today announced that the Companys Board of Directors (the Board) has appointed Chairman David (Xiaoying) Gao to the] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 10, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building Chaoyang District, Beijing 100125 86 10 6598 3111 ____________________________________________________________ (Former name or former address, if changed since last]
[China Biologic Products Reports Higher Results for the First Quarter 2012 Beijing, China, May 8, 2012 China Biologic Products, Inc. (NASDAQ: CBPO) (China Biologic or the Company), one of the leading plasma-based biopharmaceutical companies in the Peoples Republic of China (PRC), today reported higher financial results for the three months ended March 31, 2012 compared with the first quarter] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 8, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building (+86) 10-6598-3111 ____________________________________________________________ (Former name or former address, if changed since last report) see ITEM 2.02 RESULTS OF]
